Abstract
With the increasing incidence of diabetes, it is urgent to develop a reliable and safe source of insulin production. Conventional transplantation of pancreatic tissue has been demonstrated to be an efficacious method of restoring glycaemic control in type 1 diabetes. However, the lack of donors, the use of immunosuppressants and the early β-cell failure limit the use of this approach. Regenerative medicine has focused on the design and application of bioartificial pancreas to treat this disease. Islet microencapsulation technique enables the transplantation in the absence of immunosuppression by protecting the cells through an immunoisolative membrane. This membrane should be able to protect transplanted allo- and xenogenic cells from the host, while facilitating adequate transport of oxygen, nutrients, and secreted hormones. Although many different materials and immunoisolation devices build-up processes have been studied, their viability in in vivo applications has been compromised. With clarification of all obstacles to the clinical application, new strategies will be developed that would increase the islet performance after transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alsahli M, Gerich JE (2010) Abnormalities of insulin secretion and β-cell defects in type 2 diabetes. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070
Marshall SM, Flyvbjerg A (2010) Diabetic nephropathy. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Nilsson PM, Viljoen A, Wierzbicki AS (2010) Cardiovascular risk factors. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Scanlon PH (2010) Diabetic retinopathy. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Ziegler D (2010) Diabetic peripheral neuropathy. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030—response to Rathman and Giani. Diabetes Care 27:2568–2569
American Diabetes Association (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
Alberti KGMM (2010) The classification and diagnosis of diabetes mellitus. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Toeller M (2010) Lifestyle issues: diet. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Yardley JE, Alberga A, Kenny GP, Sigal RJ (2010) Lifestyle issues: exercise. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Gough S, Narendran P (2010) Insulin and insulin treatment. In: Holt RIG, Cockram C, Flyvbjerg A, Glodstein BJ (eds) Textbook of diabetes. Wiley-Blackwell, Chichester
Bailey CJ, Krentz AJ (2010) Oral antidiabetic agents. In: Textbook of diabetes. Wiley-Blackwell, Chichester, pp 452–477
Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300
Cryer PE (2010) Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am 39:641–654
Williams P (1894) Notes on diabetes treated with extract and by grafts of sheep’s pancreas. Br Med J 2:1303–1304
Ballinge WF, Lacy PE (1972) Transplantation of intact pancreatic islets in rats. Surgery 72:175–186
Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 63:977–983
Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC, Najarian JS (2001) Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 233:463–501
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238
Oberholzer J, Triponez F, Mage R, Andereggen E, Bühler L, Crétin N, Fournier B, Goumaz C, Lou J, Philippe J, Morel P (2000) Human islet transplantation – lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 69:1115–1123
Agudelo CA, Teramura Y, Iwata H (2009) Cryopreserved agarose-encapsulated islets as bioartificial pancreas: a feasibility study. Transplantation 87:29–34
Prokop A, Davidson JM (2005) Bioartificial pancreas: an update. Appl Cell Immobil Biotechnol 8B:39–54
Sumi S (2011) Regenerative medicine for insulin deficiency: creation of pancreatic islets and bioartificial pancreas. J Hepatobiliary Pancreat Sci 18:6–12
Wilson JT, Chaikof EL (2008) Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Deliv Rev 60:124–145
Teramura Y, Iwata H (2010) Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv Drug Deliv Rev 62:827–840
Nostro MC, Keller G (2012) Generation of beta cells from human pluripotent stem cells: potential for regenerative medicine. Semin Cell Dev Biol 23:701–710
Borowiak M, Melton DA (2009) How to make beta cells? Curr Opin Cell Biol 21:727–732
Bowie KM, Chang PL (1998) Development of engineered cells for implantation in gene therapy. Adv Drug Deliv Rev 33:31–43
Chick WL, Like AA, Lauris V (1975) Beta cell-culture on synthetic capillaries: artificial endocrine pancreas. Science 187:847–849
Lim F, Sun AM (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908–910
Li RH (1998) Materials for immunoisolated cell transplantation. Adv Drug Deliv Rev 33:87–109
Nafea EH, Marson A, Poole-Warren LA, Martens PJ (2011) Immunoisolating semi-permeable membranes for cell encapsulation: focus on hydrogels. J Control Release 154:110–122
Desmangles AI, Jordan O, Marquis-Weible F (2001) Interfacial photopolymerization of beta-cell clusters: approaches to reduce coating thickness using ionic and lipophilic dyes. Biotechnol Bioeng 72:634–641
Teramura Y, Kaneda Y, Iwata H (2007) Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28:4818–4825
Krol S, del Guerra S, Grupillo M, Diaspro A, Gliozzi A, Marchetti P (2006) Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett 6:1933–1939
Miura S, Teramura Y, Iwata H (2006) Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 27:5828–5835
Teramura Y, Kaneda Y, Totani T, Iwata H (2008) Behavior of synthetic polymers immobilized on a cell membrane. Biomaterials 29:1345–1355
Teramura Y, Iwata H (2008) Islets surface modification prevents blood-mediated inflammatory responses. Bioconjug Chem 19:1389–1395
Totani T, Teramura Y, Iwata H (2008) Immobilization of urokinase on the islet surface by amphiphilic poly(vinyl alcohol) that carries alkyl side chains. Biomaterials 29:2878–2883
Teramura Y, Lwata H (2009) Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 30:2270–2275
Smith C, Kirk R, West T, Bratzel M, Cohen M, Martin F, Boiarski A, Rampersaud AA (2005) Diffusion characteristics of microfabricated silicon nanopore membranes as immunoisolation membranes for use in cellular therapeutics. Diabetes Technol Ther 7:151–162
van Dijk M, Rijkers DT, Liskamp RM, van Nostrum CF, Hennink WE (2009) Synthesis and applications of biomedical and pharmaceutical polymers via click chemistry methodologies. Bioconjug Chem 20:2001–2016
Silva AI, Mateus M (2009) Development of a polysulfone hollow fiber vascular bio-artificial pancreas device for in vitro studies. J Biotechnol 139:236–249
Kadam SS, Sudhakar M, Nair PD, Bhonde RR (2010) Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules. Cytotherapy 12:982–991
Kessler L, Legeay G, Jesser C, Damgé C, Pinget M (1995) Influence of corona surface-treatment on the properties of an artificial membrane used for Langerhans islets encapsulation-permeability and biocompatibility studies. Biomaterials 16:185–191
Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Mendez R, Sandford PA (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950–951
Teramura Y, Iwata H (2009) Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation 88:624–630
Weber LM, He J, Bradley B, Haskins K, Anseth KS (2006) PEG-based hydrogels as an in vitro encapsulation platform for testing controlled beta-cell microenvironments. Acta Biomater 2:1–8
Leung A, Nielsen LK, Trau M, Timmins NE (2010) Tissue transplantation by stealth – coherent alginate microcapsules for immunoisolation. Biochem Eng J 48:337–347
Brandenberger H, Widmer F (1998) A new multinozzle encapsulation/immobilisation system to produce uniform beads of alginate. J Biotechnol 63:73–80
Basta G, Osticioli L, Rossodivita ME, Sarchielli P, Tortoioli C, Brunetti P, Calafiore R (1995) Method for fabrication of coherent microcapsules—a new potential immunoisolatory barrier for pancreatic-islet transplantation. Diabetes Nutr Metab 8:105–112
Zekorn T, Siebers U, Horcher A, Schnettler R, Zimmermann U, Bretzel RG, Federlin K (1992) Alginate coating of islets of Langerhans—in vitro studies on a new method for microencapsulation for immunoisolated transplantation. Acta Diabetol 29:41–45
de Groot M, Schuurs TA, van Schilfgaarde R (2004) Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 121:141–150
Valdés-González RA, Dorantes LM, Garibay GN, Bracho-Blanchet E, Mendez AJ, Dávila-Pérez R, Elliott RB, Terán L, White DJ (2005) Xenotransplantation of porcine neonatal islets of Langerhans and sertoli cells: a 4-year study. Eur J Endocrinol 153:419–427
Bretzel RG, Jahr H, Eckhard M, Martin I, Winter D, Brendel MD (2007) Islet cell transplantation today. Langenbecks Arch Surg 392:239–253
de Vos P, de Haan BJ, de Haan A, van Zanten J, Faas MM (2004) Factors influencing functional survival of microencapsulated islet grafts. Cell Transplant 13:515–524
Trivedi N, Keegan M, Steil GM, Hollister-Lock J, Hasenkamp WM, Colton CK, Bonner-Weir S, Weir GC (2001) Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses. Transplantation 71:203–211
Chicheportiche D, Reach G (1988) In vitro kinetics of insulin release by microencapsulated rat islets—effect of the size of the microcapsules. Diabetologia 31:54–57
Canaple L, Rehor A, Hunkeler D (2002) Improving cell encapsulation through size control. J Biomater Sci Polym 13:783–796
Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, Racanicchi L, Mancuso F, Brunetti P (2006) Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29:137–138
Barshes NR, Wyllie S, Goss JA (2005) Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 77:587–597
Gibly RF, Graham JG, Luo X, Lowe WL Jr, Hering BJ, Shea LD (2011) Advancing islet transplantation: from engraftment to the immune response. Diabetologia 54:2494–2505
Dufrane D, Steenberghe M, Goebbels RM, Saliez A, Guiot Y, Gianello P (2006) The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27:3201–3208
Sun Y, Ma X, Zhou D, Vacek I, Sun AM (1996) Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 98:1417–1422
Liu XY, Nothias JM, Scavone A, Garfinkel M, Millis JM (2010) Biocompatibility investigation of polyethylene glycol and alginate-poly-L-lysine for islet encapsulation. ASAIO J 56:241–245
Yang KC, Wu CC, Qi Z, Chen JC, Sumi S, Lin FH (2010) Comparison of bioartificial pancreas performance in the bone marrow cavity and intramuscular space. Arch Med Res 41:151–153
Cabric S, Sanchez J, Lundgren T, Foss A, Felldin M, Källen R, Salmela K, Tibell A, Tufveson G, Larsson R, Korsgren O, Nilsson B (2007) Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 56:2008–2015
De Vos P, Hillebrands JL, De Haan BJ, Strubbe JH, Van Schilfgaarde R (1997) Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 63:824–830
Wang W, Gu Y, Tabata Y, Miyamoto M, Hori H, Nagata N, Touma M, Balamurugan AN, Kawakami Y, Nozawa M, Inoue K (2002) Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 73:122–129
Su J, Hu BH, Lowe WL Jr, Kaufman DB, Messersmith PB (2010) Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 31:308–314
Contreras JL, Eckstein C, Smyth CA, Bilbao G, Vilatoba M, Ringland SE, Young C, Thompson JA, Fernández JA, Griffin JH, Eckhoff DE (2004) Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 53:2804–2814
Johansson H, Goto M, Dufrane D, Siegbahn A, Elgue G, Gianello P, Korsgren O, Nilsson B (2006) Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 6:305–312
Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B (2002) Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51:1779–1784
Luan NM, Teramura Y, Iwata H (2010) Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation. Biomaterials 31:8847–8853
Luan NM, Teramura Y, Iwata H (2011) Layer-by-layer co-immobilization of soluble complement receptor 1 and heparin on islets. Biomaterials 32:6487–6492
Chen H, Teramura Y, Iwata H (2011) Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid. J Control Release 150:229–234
Stabler CL, Sun XL, Cui W, Wilson JT, Haller CA, Chaikof EL (2007) Surface re-engineering of pancreatic islets with recombinant azido-thrombomodulin. Bioconjug Chem 18:1713–1715
Takemoto N, Teramura Y, Iwata H (2011) Islet surface modification with urokinase through DNA hybridization. Bioconjug Chem 22:673–678
Luan NM, Teramura Y, Iwata H (2011) Immobilization of soluble complement receptor 1 on islets. Biomaterials 32:4539–4545
Lin CC, Metters AT, Anseth KS (2009) Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNF alpha. Biomaterials 30:4907–4914
Cheung CY, McCartney SJ, Anseth KS (2008) Synthesis of polymerizable superoxide dismutase mimetics to reduce reactive oxygen species damage in transplanted biomedical devices. Adv Funct Mater 18:3119–3126
Cheung CY, Anseth KS (2006) Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug Chem 17:1036–1042
Lin CC, Anseth KS (2009) Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells. Biomacromolecules 10:2460–2467
Rives CB, des Rieux A, Zelivyanskaya M, Stock SR, Lowe WL Jr, Shea LD (2009) Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials 30:394–401
Chen RR, Silva EA, Yuen WW, Mooney DJ (2007) Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24:258–264
Lai Y, Schneider D, Kidszun A, Hauck-Schmalenberger I, Breier G, Brandhorst D, Brandhorst H, Iken M, Brendel MD, Bretzel RG, Linn T (2005) Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79:1530–1536
Olsson R, Maxhuni A, Carlsson PO (2006) Revascularization of transplanted pancreatic islets following culture with stimulators of angiogenesis. Transplantation 82:340–347
Matsui M, Tabata Y (2012) Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater 8:1792–1801
Oliviero O, Ventre M, Netti PA (2012) Functional porous hydrogels to study angiogenesis under the effect of controlled release of vascular endothelial growth factor. Acta Biomater 8:3294–3301
Balamurugan AN, Gu Y, Tabata Y, Miyamoto M, Cui W, Hori H, Satake A, Nagata N, Wang W, Inoue K (2003) Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival. Pancreas 26:279–285
Teramura Y, Minh LN, Kawamoto T, Iwata H (2010) Microencapsulation of islets with living cells using polyDNA-PEG-lipid conjugate. Bioconjug Chem 21:792–796
Dufour JM, Lord SJ, Kin T, Rayat GR, Dixon DE, Bleackley RC, Korbutt GS, Rajotte RV (2007) Comparison of successful and unsuccessful islet/sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice. Cell Transplant 16:1029–1038
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Crisóstomo, J., Coelho, J.F.J., Seiça, R. (2013). Bioartificial Pancreas: In the Road to Clinical Application. In: Coelho, J. (eds) Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment. Advances in Predictive, Preventive and Personalised Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6010-3_5
Download citation
DOI: https://doi.org/10.1007/978-94-007-6010-3_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6009-7
Online ISBN: 978-94-007-6010-3
eBook Packages: MedicineMedicine (R0)